Home » Newsletters » BioWorld Science

BioWorld Science

July 28, 2006

View Archived Issues

Genentech and Inotek collaborate on PARP inhibitors for cancer

Kos reports findings from flush provocation study of Niaspan CF with aspirin

Withania somnifera improves muscle strength in elderly subjects

Intravenous immunoglobulin therapy for AD

Elan present novel gamma secretase inhibitors

Meiji Seika signs license agreement for progesterone modulator with Tokai

NCX-4016 to be advanced as insulin sensitizing agent for type 2 diabetes

Liponex prepares for phase I/II study of CRD-5 for dyslipidemia

Xechem accelerates construction of Nicosan production facility

ComGenex changes name to AMRI Hungary

Avalon and ChemDiv collaboration to discover oncology therapeutics

Calando selects Agilent for siRNA production

SPA completed for confirmatory study of Genasense in CLL

Orphan drug status for novel antifolate PDX in T-cell lymphoma

Oral nalmefene demonstrates positive results in pilot smoking cessation study

Quadramet studied in phase III trial for osteoblastic metastases

New phase II study for Genz-112638 in Gaucher's disease

LL-4218 cleared to begin phase II trials for psoriasis in India

Agents for dermatological conditions prepared and tested

Recent patents impart new therapeutics for cardiovascular disorders

New tumor necrosis factor-alpha inhibitors for immunological disorders reported by 4 AZA Bioscience

NDA filed for Xyzal

Zanitek receives German approval

GSK files fluticasone furoate for seasonal and perennial rhinitis in U.S. and E.U.

Improved liver transplantation outcome with novel iNOS inhibitor, FK-330

JAK3 inhibition with R-935 prevents organ rejection in rat heart transplant model

Clioquinol analogue shows improved cognition in animal models of AD and positive phase I results

Potential benefit of pomegranate juice in slowing prostate cancer progression

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...